Benzinga
Benzinga
Benzinga
giovedì, settembre 24

BeOne Medicines Ltd

ONCNASDAQ
Trade with Public
Trade with Public
$365.00
-3.08-0.84%
In chiusura: Sep 22, 5:00 PM EST
$356.81
-11.27-3.06%
Pre-mercato: 5:22 AM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

BeOne Medicines Market Sentiment

Market sentiment signals for BeOne Medicines (ONC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy
Short Interest▼ 1.8% short float
Options Flow— N/A
Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

20 analysts

Options Flow (P/C)

—

Avg Consensus PT

$386

+8.1%

Highest Price Target

$454

+27.2%

TD Cowen

Lowest Price Target

$311

-12.8%

RBC Capital

Short Interest

1.8%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

DateFirmAnalyst & AccuracyUpside / DownsidePT ChangeActionRating
Sep 10, 2026Barclays
Etzer Darout—
+16.3%$407 → $415MaintainedOverweight
Aug 6, 2026TD Cowen
Yaron Werber—
+27.2%$424 → $454MaintainedBuy
More with Benzinga EdgeGet Access

Insider & Market Activity News

Aaron Rosenberg Implements A Sell Strategy: Offloads $361K In BeOne Medicines Stock

It was reported on August 5, that Aaron Rosenberg, Chief Financial Officer at BeOne Medicines (NASDAQ:ONC) executed a significant insider sell, according to an SEC filing. What Happened: After conducting a thorough
Benzinga Insights

Insider Selling: Chan Henry Lee Unloads $337K Of BeOne Medicines Stock

On August 3, a recent SEC filing unveiled that Chan Henry Lee, SVP at BeOne Medicines (NASDAQ:ONC) made an insider sell. What Happened: Lee's recent move involves selling 1,044 shares of BeOne Medicines. This
Benzinga Insights

Lai Wang Executes Sell Order: Offloads $295K In BeOne Medicines Stock

It was reported on June 25, that Lai Wang, President at BeOne Medicines (NASDAQ:ONC) executed a significant insider sell, according to an SEC filing. What Happened: According to a Form 4 filing with the U.S. Securities
Benzinga Insights

Chief Executive Officer At BeOne Medicines Sells $933K Of Stock

Disclosed on June 25, JOHN OYLER, Chief Executive Officer at BeOne Medicines (NASDAQ:ONC), executed a substantial insider sell as per the latest SEC filing. What Happened: OYLER's decision to sell 3,410 shares of
Benzinga Insights

President and COO At BeOne Medicines Sells $356K Of Stock

Xiaobin Wu, President and COO at BeOne Medicines (NASDAQ:ONC), reported an insider sell on June 25, according to a new SEC filing. What Happened: Wu opted to sell 1,292 shares of BeOne Medicines, according to a Form 4
Benzinga Insights

Lai Wang Executes Sell Order: Offloads $310K In BeOne Medicines Stock

Revealing a significant insider sell on June 18, Lai Wang, President at BeOne Medicines (NASDAQ:ONC), as per the latest SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on
Benzinga Insights

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved